Victory Capital Management Inc. reduced its stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 14.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 50,129 shares of the medical instruments supplier's stock after selling 8,460 shares during the period. Victory Capital Management Inc. owned 0.07% of West Pharmaceutical Services worth $15,047,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently made changes to their positions in WST. Avantax Advisory Services Inc. lifted its stake in West Pharmaceutical Services by 11.0% during the first quarter. Avantax Advisory Services Inc. now owns 907 shares of the medical instruments supplier's stock valued at $359,000 after purchasing an additional 90 shares during the last quarter. Ameritas Investment Partners Inc. lifted its stake in West Pharmaceutical Services by 81.2% during the first quarter. Ameritas Investment Partners Inc. now owns 1,910 shares of the medical instruments supplier's stock valued at $756,000 after purchasing an additional 856 shares during the last quarter. O Shaughnessy Asset Management LLC lifted its stake in West Pharmaceutical Services by 11.3% during the first quarter. O Shaughnessy Asset Management LLC now owns 2,698 shares of the medical instruments supplier's stock valued at $1,068,000 after purchasing an additional 273 shares during the last quarter. Clearbridge Investments LLC lifted its stake in West Pharmaceutical Services by 0.7% during the first quarter. Clearbridge Investments LLC now owns 4,495 shares of the medical instruments supplier's stock valued at $1,779,000 after purchasing an additional 31 shares during the last quarter. Finally, Lake Street Advisors Group LLC lifted its position in shares of West Pharmaceutical Services by 13.6% in the 1st quarter. Lake Street Advisors Group LLC now owns 792 shares of the medical instruments supplier's stock valued at $313,000 after acquiring an additional 95 shares in the last quarter. 93.90% of the stock is owned by institutional investors and hedge funds.
West Pharmaceutical Services Trading Up 2.5 %
Shares of NYSE:WST traded up $7.57 during mid-day trading on Wednesday, hitting $311.67. The stock had a trading volume of 437,683 shares, compared to its average volume of 574,460. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.23 and a current ratio of 3.00. The company has a market cap of $22.57 billion, a PE ratio of 46.24, a P/E/G ratio of 23.20 and a beta of 1.00. West Pharmaceutical Services, Inc. has a 12-month low of $265.00 and a 12-month high of $413.70. The company's 50 day moving average is $306.23 and its 200-day moving average is $314.97.
West Pharmaceutical Services (NYSE:WST - Get Free Report) last issued its quarterly earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 EPS for the quarter, beating the consensus estimate of $1.50 by $0.35. The business had revenue of $746.90 million during the quarter, compared to the consensus estimate of $709.62 million. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. The firm's quarterly revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.16 EPS. On average, sell-side analysts predict that West Pharmaceutical Services, Inc. will post 6.67 EPS for the current year.
West Pharmaceutical Services Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 20th. Investors of record on Wednesday, November 13th will be given a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 0.27%. The ex-dividend date is Wednesday, November 13th. This is an increase from West Pharmaceutical Services's previous quarterly dividend of $0.20. West Pharmaceutical Services's dividend payout ratio is 12.46%.
Insider Buying and Selling at West Pharmaceutical Services
In other West Pharmaceutical Services news, VP Charles Witherspoon sold 703 shares of the company's stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $310.40, for a total value of $218,211.20. Following the transaction, the vice president now owns 1,253 shares in the company, valued at approximately $388,931.20. This represents a 35.94 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.53% of the company's stock.
West Pharmaceutical Services Company Profile
(
Free Report)
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Read More
Before you consider West Pharmaceutical Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and West Pharmaceutical Services wasn't on the list.
While West Pharmaceutical Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
